Evidence map›Paper›PMID 40817088›Full record

ArticleNature communications2025

A chronic Acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections.

Clay D Jackson-Litteken, Gisela Di Venanzio, Manon Janet-Maitre, Ítalo A Castro, Joseph J Mackel, Leslie D Wilson, David A Rosen, Carolina B López, Mario F Feldman

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Quorum sensing geneFrontiers in microbiology · 2026
    Article
  11. IntracellularProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Clay D Jackson-LittekenDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA.
Gisela Di VenanzioDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA.
Manon Janet-MaitreDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0001-8954-7245
Ítalo A CastroDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0001-7885-7547
Joseph J MackelDepartment of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, MO, USA.
Leslie D WilsonDivision of Comparative Medicine, Research Animal Diagnostic Laboratory, Washington University School of Medicine, Saint Louis, MO, USA.
David A RosenDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0003-1081-772X
Carolina B LópezDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0002-7669-6572
Mario F FeldmanDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA. mariofeldman@wustl.edu.ORCID http://orcid.org/0000-0003-4497-0976

Funding

Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
Defective Viral genomes in RSV pathogenesisR01AI137062 · NIAID · WASHINGTON UNIVERSITY · PI Carolina B. Lopez · 2018 to 2026
$4.2M
Pediatric Cardiovascular and Pulmonary Research Training Program.T32HL125241 · NHLBI · WASHINGTON UNIVERSITY · PI Juliane Bubeck Wardenburg, Kory J. Lavine · 2015 to 2026
$4.1M
Phenylacetic acid catabolism, a novel stress-response pathway in Acinetobacter baumanniiR01AI166359 · NIAID · WASHINGTON UNIVERSITY · PI Mario Feldman · 2022 to 2026
$3.2M
American Association of Immunologists (American Association of Immunologists, Inc.) 5T32HL125241-07NHLBI NIH HHS T32 HL125241NIAID NIH HHS R01 AI137062NIAID NIH HHS R01 AI166359NIAID NIH HHS T32 AI007172U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI166359U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) T32AI007172
6 · The paper itself

Abstract

Acinetobacter baumannii causes prolonged infections that disproportionately affect immunocompromised populations. Our understanding of A. baumannii respiratory pathogenesis relies on an acute murine infection model with limited clinical relevance that employs an unnaturally high number of bacteria and requires assessment of bacterial load at 24-36 h post-infection. Here, we demonstrate that low intranasal inoculums in tlr4 mutant mice allows for infections lasting at least 3 weeks. Using this "chronic infection model" we determine the adhesin InvL is a virulence factor required during later stages of infection, despite being dispensable in the early phase. We also demonstrate that the chronic model enables distinction between antibiotics that, although initially reduce bacterial burden, either lead to clearance or result in the formation of potential bacterial persisters. To illustrate how our model can be applied to study polymicrobial infections, we inoculate mice with an active A. baumannii infection with Staphylococcus aureus or Klebsiella pneumoniae. We find that S. aureus exacerbates infection, while K. pneumoniae enhances A. baumannii clearance. In all, the chronic model overcomes some limitations of the acute pulmonary model, expanding our capabilities to study A. baumannii pathogenesis and lays the groundwork for the development of similar models for other opportunistic pathogens.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsCoinfectionPneumonia, BacterialVirulence FactorsAnimalsChronic DiseaseDisease Models, AnimalFemaleKlebsiella InfectionsKlebsiella pneumoniaeMiceMice, Inbred C57BLStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsTlr4 protein, mouseToll-Like Receptor 4Virulence Factors

Identifiers

PMID40817088
PMCPMC12356904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.